000 | 01239 a2200337 4500 | ||
---|---|---|---|
005 | 20250517020750.0 | ||
264 | 0 | _c20150518 | |
008 | 201505s 0 0 fre d | ||
022 | _a1769-6917 | ||
024 | 7 |
_a10.1016/j.bulcan.2015.01.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLieutenant, Vincent | |
245 | 0 | 0 |
_a[Is Herceptin(®) (trastuzumab) by subcutaneous a mini revolution? Pharmaco-economic study]. _h[electronic resource] |
260 |
_bBulletin du cancer _cMar 2015 |
||
300 |
_a270-6 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTrastuzumab |
700 | 1 | _aToulza, Émilie | |
700 | 1 | _aPommier, Martine | |
700 | 1 | _aLortal-Canguilhem, Barbara | |
773 | 0 |
_tBulletin du cancer _gvol. 102 _gno. 3 _gp. 270-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bulcan.2015.01.007 _zAvailable from publisher's website |
999 |
_c24664236 _d24664236 |